Citi Pharma Limited (PSX:CPHL)
Pakistan · Delayed Price · Currency is PKR 83.34
-1.31 (-1.55%)
At close: Jul 18, 2025
Citi Pharma Market Cap
Citi Pharma has a market cap or net worth of 19.04 billion as of July 18, 2025. Its market cap has increased by 192.42% in one year.
Market Cap
19.04B
Enterprise Value
20.66B
Revenue
12.97B
Ranking
n/a
PE Ratio
22.91
Stock Price
83.34
Market Cap Chart
Since July 9, 2021, Citi Pharma's market cap has increased from 7.14B to 19.04B, an increase of 166.49%. That is a compound annual growth rate of 27.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 18, 2025 | 19.04B | 22.36% |
| Dec 31, 2024 | 15.56B | 186.90% |
| Dec 29, 2023 | 5.42B | -1.70% |
| Dec 30, 2022 | 5.52B | -32.47% |
| Dec 31, 2021 | 8.17B | 14.35% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pakistan | 124.98B |
| Abbott Laboratories (Pakistan) | 106.88B |
| Highnoon Laboratories | 57.72B |
| AGP Limited | 55.26B |
| The Searle Company | 48.22B |
| Shifa International Hospitals | 34.48B |
| Ferozsons Laboratories | 16.96B |
| Otsuka Pakistan | 3.35B |